Q3 2025 profits of TASI firms ex-Aramco up to SAR 46.1B

Tadawul-listed companies, excluding Saudi Aramco, reported a 5% rise in the Q3 2025 aggregate net profit to SAR 46.1 billion, primarily due to the positive results of the banks and real estate development sectors.

Including Saudi Aramco, the third-quarter combined net profit rose 2% year-on-year (YoY) to around SAR 143.4 billion. The oil giant accounted for 68% of aggregate earnings as its bottom line reached SAR 97.3 billion.

Aramco’s financial results included non-recurring losses of SAR 5.3 billion. Excluding these losses, Aramco’s profit would amount to SAR 102.6 billion, up 5%, bringing the total market profit to SAR 148.7 billion, representing a 5% increase.

*Excluding REITs, Ataa Educational and NCLE due to different fiscal years (FYs).

**Included net gains from exceptional items totaling SAR 16.5 bln, as follows: SAR 11.6 bln from the distribution of Almarai shares to Savola shareholders; SAR 1.4 bln in provisions related to Savola’s exit from subsidiaries in Iran and Sudan; an incremental provision of SAR 1.2 bln related to SABIC’s subsidiary Clariant; SAR 12.9 bln in gains from the sale of stc’s telecommunications towers subsidiary; and SAR 5.69 bln in losses from recognizing one-off expenses related to the final settlement of Saudi Electricity Co. (SEC).

***Included non-recurring expenses of SAR 1.07 bln on SABIC’s restructuring; SAR 1.06 bln from loan restructuring at Tasnee; SAR 918 mln from a land sale by Jabal Omar Development Co.; SAR 418 mln from the sale of subsidiaries by AYYAN Investment Co.; and SAR 429 mln in restructuring gains; and SAR 200 mln in impairment asset losses by Sipchem.

****Includes non-recurring net losses of SAR 5.28 bln, consisting of an impairment provision of SAR 4.52 bln related to SABIC; non-recurring expenses of SAR 1.08 bln related to flynas IPO; an impairment loss of SAR 0.17 bln for the Noor 3 plant in Morocco; settlement compensation gains of SAR 0.42 bln for ACWA Power; losses of SAR 0.37 bln for Chemanol resulting from asset impairment expenses and additional provisions for subsidiaries; and reversal gains of provisions amounting to SAR 0.21 bln for Nama Chemicals.

*****Included losses of SAR 5.3 bln resulting from the closure of one of Aramco’s refining, chemicals, and marketing facilities, in addition to Tasnee’s share of the impairment in its investment in Tronox, amounting to SAR 367 mln.